Hepatitis Monthly

Published by: Kowsar

Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters

Nazlim Aktug Demir 1 , Servet Kolgelier 2 , Serap Ozcimen 3 , Gokhan Gungor 4 , Sua Sumer 1 , * , Lutfi Saltuk Demir 5 , Ahmet Cagkan Inkaya 6 and Onur Ural 1
Authors Information
1 Infectious Diseases and Clinical Microbiology Department, Selcuk University, Konya, Turkey
2 Infectious Diseases and Clinical Microbiology Department, Adiyaman University, Adiyaman, Turkey
3 Infectious Diseases and Clinical Microbiology Department, Konya State Hospital, Konya, Turkey
4 Gastroenterology Department, Konya Education and Training Hospital, Konya, Turkey
5 Public Health Department, Necmettin Erbakan University, Konya, Turkey
6 Infectious Diseases and Clinical Microbiology Department, Hacettepe University, Ankara, Turkey
Article information
  • Hepatitis Monthly: April 01, 2014, 14 (4); e16975
  • Published Online: April 1, 2014
  • Article Type: Research Article
  • Received: December 17, 2013
  • Revised: February 24, 2014
  • Accepted: March 6, 2014
  • DOI: 10.5812/hepatmon.16975

To Cite: Demir N A, Kolgelier S, Ozcimen S, Gungor G, Sumer S, et al. Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters, Hepat Mon. 2014 ; 14(4):e16975. doi: 10.5812/hepatmon.16975.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4): 529-38[DOI][PubMed]
  • 2. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004; 99(6): 1160-74[DOI][PubMed]
  • 3. Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther. 2009; 30(6): 557-76[DOI][PubMed]
  • 4. Thampanitchawong P, Piratvisuth T. Liver biopsy:complications and risk factors. World J Gastroenterol. 1999; 5(4): 301-4[PubMed]
  • 5. Campbell MS, Reddy KR. Review article: the evolving role of liver biopsy. Aliment Pharmacol Ther. 2004; 20(3): 249-59[DOI][PubMed]
  • 6. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22(6): 696-9[PubMed]
  • 7. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38(2): 518-26[DOI][PubMed]
  • 8. Guma JR, Marti V, Bailen JL, Padro JM, Garcia J, Auge JM. [The single coronary artery. Presentation of a case]. Rev Esp Cardiol. 1990; 43(3): 201-2[PubMed]
  • 9. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011; 53(3): 726-36[DOI][PubMed]
  • 10. Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol. 2005; 100(3): 616-23[DOI][PubMed]
  • 11. Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, et al. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol. 2006; 101(3): 547-55[DOI][PubMed]
  • 12. McCuskey RS. Preface. Comp Hepatol. 2004; 3 Suppl 1[DOI][PubMed]
  • 13. Halfon P, Bourliere M, Penaranda G, Deydier R, Renou C, Botta-Fridlund D, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol. 2005; 4: 6[DOI][PubMed]
  • 14. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem. 2004; 50(8): 1344-55[DOI][PubMed]
  • 15. Giannini E, Risso D, Testa R. Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients. Am J Gastroenterol. 2001; 96(3): 918-9[DOI][PubMed]
  • 16. Iacobellis A, Fusilli S, Mangia A, Clemente R, Festa V, Giacobbe A, et al. Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis. Aliment Pharmacol Ther. 2005; 22(9): 769-74[DOI][PubMed]
  • 17. Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, et al. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol. 2006; 101(11): 2537-45[DOI][PubMed]
  • 18. Lu LG, Zeng MD, Mao YM, Li JQ, Qiu DK, Fang JY, et al. Relationship between clinical and pathologic findings in patients with chronic liver diseases. World J Gastroenterol. 2003; 9(12): 2796-800[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments